Display options
Cite
Waterhouse DN, Bally MB. Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy. Nanomedicine (Lond). 2006;1(3):359-63doi: 10.2217/17435889.1.3.359.
Waterhouse, D. N., & Bally, M. B. (2006). Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy. Nanomedicine (London, England), 1(3), 359-63. https://doi.org/10.2217/17435889.1.3.359
Waterhouse, Dawn N, and Bally, Marcel B. "Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy." Nanomedicine (London, England) vol. 1,3 (2006): 359-63. doi: https://doi.org/10.2217/17435889.1.3.359
Waterhouse DN, Bally MB. Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy. Nanomedicine (Lond). 2006 Oct;1(3):359-63. doi: 10.2217/17435889.1.3.359. PMID: 17716167.
Copy Download .nbib Format: NLM
Share it on

Nanomedicine (Lond). 2006 Oct;1(3):359-63. doi: 10.2217/17435889.1.3.359.

Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy.

Nanomedicine (London, England)

Dawn N Waterhouse, Marcel B Bally

Affiliations

  1. Department of Advanced Therapeutics, BC Cancer Agency, Vancouver, BC, Canada. [email protected]

PMID: 17716167 DOI: 10.2217/17435889.1.3.359

[No abstract available.]

Publication Types